Unveiling neoantigen-directed cancer treatment
Drug Target Review
JUNE 9, 2023
One aspect of the collaboration focuses on screening and identification of therapeutic T-cell receptors (TCRs) to target a common shared neoantigen present in many cancer patients. While tumour cells share a majority of their DNA with healthy cells, they also carry numerous unique mutations.
Let's personalize your content